secwatch.observer — SEC 8-K summary
======================================

Issuer:     RespireRx Pharmaceuticals Inc. (—)
CIK:        0000849636
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0001493152-24-014816
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RespireRx enters $100K demand note with director Nasiek; warrant for 33.3M shares
--------------------------------------------------------------------------------

- $100,000 demand promissory note issued to Dariusz Nasiek and Sara Nasiek JTTEN; 10% interest payable on demand.
- Warrant to purchase 33,333,333 shares of common stock at $0.0015/share, exercisable for 5 years.
- Proceeds used for working capital, R&D, and general corporate purposes.
- Dariusz Nasiek is a Board member; transaction is a related-party arrangement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/0001493152-24-014816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer